TYSABRI: payments to doctors
Payments that named TYSABRI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13.9M
- Providers
- 9,446
- Transactions
- 101,613
- Average per transaction
- $137
The per-transaction average — $137 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,446 providers the average total is $1,474, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biogen | $13,928,097 | 100.0% |